We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
-14.04%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$627M
AUM Growth
+$7.4M
(+1.2%)
Cap. Flow
+$125M
Cap. Flow
% of AUM
20.01%
Top 10 Holdings %
Top 10 Hldgs %
49.49%
Holding
67
New
8
Increased
17
Reduced
20
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPNE
SeaSpine Holdings Corporation Common Stock
SPNE
|
+$30.1M |
| 2 |
NVTR
Nuvectra Corporation Common Stock
NVTR
|
+$14.9M |
| 3 |
Nektar Therapeutics
NKTR
|
+$14.4M |
| 4 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
+$14.3M |
| 5 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
+$14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NeoGenomics
NEO
|
+$22.2M |
| 2 |
SHPG
Shire pic
SHPG
|
+$11.4M |
| 3 |
KTWO
K2M Group Holdings, Inc
KTWO
|
+$7.93M |
| 4 |
SGMO
SANGAMO THERAPEUTICS INC
SGMO
|
+$4.51M |
| 5 |
DVAX
Dynavax Technologies
DVAX
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 75.2% |
| 2 | Communication Services | 3.64% |
| 3 | Energy | 0.8% |
| 4 | Financials | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioMarin Pharmaceuticals
BMRN
$11.6B
| $5.27M | 0.84% |
61,839
-459
| -0.7% | -$43.7K |
|
27
Alkermes
ALKS
$8.22B
| $5.03M | 0.8% |
170,533
+138,501
| +432% | +$5.1M |
|
|
LHCG
28
DELISTED
LHC Group LLC
LHCG
| $5.03M | 0.8% |
53,587
-360
| -0.7% | -$34.4K |
|
29
Simulations Plus
SLP
$369M
| $5M | 0.8% |
251,105
+193,557
| +336% | +$3.82M |
|
30
Trupanion
TRUP
$1.07B
| $4.88M | 0.78% |
+191,808
| New | +$5.16M |
|
31
Viatris
VTRS
$20.4B
| $4.58M | 0.73% |
+167,187
| New | +$5.42M |
|
32
Globus Medical
GMED
$10.7B
| $4.47M | 0.71% |
103,217
-691
| -0.7% | -$34.5K |
|
33
Teva Pharmaceuticals
TEVA
$40.8B
| $4.33M | 0.69% |
+280,607
| New | +$5.75M |
|
34
OrthoPediatrics
KIDS
$519M
| $4.27M | 0.68% |
122,394
-847
| -0.7% | -$26.8K |
|
35
Vertex Pharmaceuticals
VRTX
$121B
| $4.08M | 0.65% |
24,615
-172
| -0.7% | -$29.8K |
|
36
Bio-Techne
TECH
$11.2B
| $3.63M | 0.58% |
100,192
-672
| -0.7% | -$28.1K |
|
|
BLUE
37
DELISTED
bluebird bio
BLUE
| $3.27M | 0.52% |
2,548
-16
| -0.6% | -$24.5K |
|
|
DVAX
38
DELISTED
Dynavax Technologies
DVAX
| $3.16M | 0.5% |
345,339
-200,926
| -37% | -$2.22M |
|
|
NXTM
39
DELISTED
NxStage Medical Inc.
NXTM
| $2.82M | 0.45% |
98,411
-52,796
| -35% | -$1.5M |
|
40
QuidelOrtho
QDEL
$1.14B
| $2.66M | 0.42% |
54,511
-367
| -0.7% | -$21.9K |
|
41
HealthStream
HSTM
$819M
| $2.18M | 0.35% |
90,210
-776
| -0.9% | -$20.1K |
|
42
iShares Biotechnology ETF
IBB
$9.34B
| $2.05M | 0.33% |
21,291
| – | – |
|
|
TLGT
43
DELISTED
Teligent, Inc
TLGT
| $2.01M | 0.32% |
146,557
+32,047
| +28% | +$838K |
|
44
Invesco S&P SmallCap Health Care ETF
PSCH
$163M
| $1.86M | 0.3% |
51,855
| – | – |
|
45
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $1.58M | 0.25% |
18,241
| – | – |
|
46
iShares US Medical Devices ETF
IHI
$3.13B
| $1.51M | 0.24% |
45,480
| – | – |
|
47
LeMaitre Vascular
LMAT
$2.32B
| $1.16M | 0.19% |
49,217
-400
| -0.8% | -$10.9K |
|
|
CLLS
48
Cellectis
CLLS
$277M
| $437K | 0.07% |
26,234
-50,091
| -66% | -$1.16M |
|
49
AbbVie
ABBV
$443B
| $383K | 0.06% |
4,159
| – | – |
|
50
Pfizer
PFE
$143B
| $374K | 0.06% |
9,020
| – | – |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, First Light Asset Management held 67 positions worth $627M, up 1.2% from $620M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
First Light Asset Management deployed $125M of net new capital in Q4 2018, opening 8 new positions and adding to 17 existing holdings. Its largest new stake was SeaSpine Holdings Corporation Common Stock: 1,785,071 shares worth $32.6M.
By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 84% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was NeoGenomics, an estimated $22.2M trimmed.
- First Light Asset Management's largest Q4 2018 buy was SeaSpine Holdings Corporation Common Stock: 1,785,071 shares worth $32.6M.
- First Light Asset Management added most to Nuvectra Corporation Common Stock in Q4 2018, an estimated $14.9M increase.
- First Light Asset Management's biggest Q4 2018 reduction was NeoGenomics, cutting an estimated $22.2M.
- First Light Asset Management fully exited K2M Group Holdings, Inc in Q4 2018, selling an estimated $7.93M.
- First Light Asset Management's ten largest holdings make up 49% of its $627M portfolio in Q4 2018.
- First Light Asset Management opened 8 new positions and closed 7 in Q4 2018.
- First Light Asset Management's portfolio value rose 1.2% quarter-over-quarter to $627M.
Based on First Light Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.